ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1

ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1

No trades
See on Supercharts

Key facts today

Elon Musk's endorsement of Eli Lilly's Mounjaro boosts demand for GLP-1 inhibitors. However, rising generics pose challenges as Eli Lilly increases production ahead of key patent expirations by 2026.
Analyze the impactAnalyze the impact
Market capitalization
‪773.92 T‬ARS
125.249ARS
‪1.54 T‬ARS
‪10.05 T‬ARS
Beta (1Y)
0.40

About Eli Lilly and Company


CEO
David A. Ricks
Headquarters
Indianapolis
Website
Founded
1876
ISIN
ARDEUT111192
FIGI
BBG000HFTQS8
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US532457BZ0
ELI LILLY 20/60
Yield to maturity
7.23%
Maturity date
Sep 15, 2060
XS238628644
ELI LILLY 21/43
Yield to maturity
7.21%
Maturity date
Sep 14, 2043
US532457BY3
ELI LILLY 20/50
Yield to maturity
7.09%
Maturity date
May 15, 2050
US532457BS6
ELI LILLY 19/39
Yield to maturity
6.26%
Maturity date
Mar 15, 2039
US532457BT4
ELI LILLY 19/49
Yield to maturity
6.23%
Maturity date
Mar 15, 2049
US532457BU1
ELI LILLY 19/59
Yield to maturity
6.22%
Maturity date
Mar 15, 2059
LLY4217068
Eli Lilly and Company 3.7% 01-MAR-2045
Yield to maturity
6.02%
Maturity date
Mar 1, 2045
LLY4492882
Eli Lilly and Company 3.95% 15-MAY-2047
Yield to maturity
5.79%
Maturity date
May 15, 2047
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063
Yield to maturity
5.79%
Maturity date
Feb 27, 2063
LLY5871804
Eli Lilly and Company 5.2% 14-AUG-2064
Yield to maturity
5.78%
Maturity date
Aug 14, 2064
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064
Yield to maturity
5.76%
Maturity date
Feb 9, 2064

Explore more bonds